Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Postprandial Hyperglycemia: early-phase trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Postprandial Hyperglycemia: 5 US clinical trials tracked, none currently recruiting.
Postprandial Hyperglycemia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Iowa State University, running 1 of these trials.
Enrollment posture brief
Registry condition postprandial-hyperglycemia
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Postprandial Hyperglycemia has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Postprandial Hyperglycemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Postprandial Hyperglycemia is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Postprandial Hyperglycemia research.
Iowa State University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Postprandial Hyperglycemia trials plan to enrol fewer than 100 people.
Median target enrolment is 21 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Postprandial Hyperglycemia research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
Ohio State University
NCT03624569
The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans
Purdue University
NCT05349916
Glycemic Response of Whole Beans and Bean Products
Iowa State University
NCT06630312
AVACEN Treatment Method and Postprandial Blood Glucose
San Diego State University
NCT04018976
Evaluating the Acute Glycemic Response to Different Strategies of Breaking Up Sedentary Time
Arizona State University
NCT04144920
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Postprandial Hyperglycemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Postprandial Hyperglycemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Postprandial Hyperglycemia page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Postprandial Hyperglycemia trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Iowa State University sponsors the most Postprandial Hyperglycemia trials on record, review their full trial history before evaluating a specific study. See Iowa State University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postprandial Hyperglycemia condition card totals 5 registered trials; most-linked intervention Alpha galactosidase; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.